ValenTx is a well-funded early-stage medical device company that has been developing a non-surgical, implantable medical therapy to treat morbid obesity and Type II Diabetes. The Company has successfully evaluated this treatment and has generated unsurpassed efficacy data in a series of human clinical trials, and is aggressively growing its Operations function in support of expanding the therapy’s utility.
Location: United States, Minnesota, Maple Grove
Employees: 11-50
Total raised: $22M
Founded date: 2002
Investors 2
| Date | Name | Website |
| - | TGap Ventu... | tgapvcfund... |
| - | Kaiser Per... | kpventures... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 08.09.2009 | Series B | $22M | - |
Mentions in press and media 5
| Date | Title | Description |
| 02.11.2010 | Top 5 anti-obesity medical devices at Cleveland Clinic summit | Covid-19’s terrible toll on diabetes patients. What can be done? The public health crisis has undermined the economy and made people with chronic conditions more vulnerable and stressed. Learn more with a new report from Omada Health. Omada... |
| 08.09.2009 | ValenTx Raises $22M In Series B | Carpinteria-based ValenTx, a developer of medical devices for addressing morbid obesity, announced today that it has raised $22M in a Series B financing round. The round was led by SV Life Sciences, and also included Covidien Ventures, Sapi... |
| 08.09.2009 | Californian ValenTx Completes $22 Million Series B Financing | Carpinteria, Ca.-based ValenTx closed a $22m Series B Preferred Stock financing in a round led by SV Life Sciences and joined by Covidien Ventures and the Company’s existing venture capital investors Sapient Capital, EDF Ventures, Kaiser Pe... |
| 27.08.2009 | ValenTX Raises $20.28M | Carpinteria-based ValenTX, a developer of treatments for obesity, has raised $20.28M in an equity funding round, according to a regulatory filing by the firm Thursday. Details on the funding have not been released by the company. ValenTx ha... |
| - | Top 5 anti-obesity medical devices at Cleveland Clinic summit | A panel at Cleveland Clinic’s Medical Innovations Summit focused on five companies developing innovative obesity-fighting medical devices that have yet to hit the market. The companies that participated were “handpicked” by Philip Schauer, ... |